These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Efficacy of clofazimine in the prophylaxis and suppression of reactive phases of lepromatous leprosy. Karat AB; Jeevaratnam A; Karat S; Rao PS Int J Lepr Other Mycobact Dis; 1971; 39(4):838-41. PubMed ID: 5170472 [No Abstract] [Full Text] [Related]
5. Forty-four months' experience in the treatment of leprosy with clofazimine (Lamprene (Geigy)). Schulz EJ Lepr Rev; 1971 Sep; 42(3):178-87. PubMed ID: 5151819 [No Abstract] [Full Text] [Related]
6. Effects of the administration of B663 [G 30 320, Lamprene, clofazimine (Geigy)] on three groups of lepromatous and borderline of leprosy. Rodriguez JN; Abalos RM; Reich CV; Tolentino JG Int J Lepr Other Mycobact Dis; 1974; 42(3):276-88. PubMed ID: 4617715 [No Abstract] [Full Text] [Related]
7. Bacteriological effect of Lamprene (clofazimine) in lepromatous leprosy (report of one year's treatment of 44 patients with 100 mg of Lamprene daily). Leiker DL; Blenska W; Carling D; Fitzherbert M; Larssen P Lepr Rev; 1971 Jun; 42(2):125-30. PubMed ID: 4948481 [No Abstract] [Full Text] [Related]
9. Chemotherapeutic trials in leprosy. 3. Pilot trial of a riminophenazine derivative. B.663, in the treatment of lepromatous leprosy. Pettit JH; Rees RJ; Ridley DS Int J Lepr Other Mycobact Dis; 1967; 35(1):25-33. PubMed ID: 5336368 [No Abstract] [Full Text] [Related]
10. The treatment of erythema nodosum leprosum with B.663. A controlled study. Pettit JH Int J Lepr Other Mycobact Dis; 1967; 35(1):11-6. PubMed ID: 4290017 [No Abstract] [Full Text] [Related]
11. A Traditional NSAID Aspirin along with Clofazimine in Erythema Nodosum Leprosum Reaction: Study of Six Cases. Sharma PK; Singh DK Indian J Lepr; 2016 Sep; 87(4):249-253. PubMed ID: 29762954 [TBL] [Abstract][Full Text] [Related]
13. B.663 (Geigy 30. 320) in the treatment of leprosy. A preliminary report. Devadason C Acta Trop; 1969; 26(3):265-9. PubMed ID: 4391239 [No Abstract] [Full Text] [Related]
14. The treatment of corticosteroid-dependent lepromatous patients in persistent Erythema nodosum leprosum with clofazimine. Imkamp FM Lepr Rev; 1973 Sep; 44(3):127-30. PubMed ID: 4788877 [No Abstract] [Full Text] [Related]
15. Bangkok Workshop on Leprosy Research. Treatment of reactions and nerve damage. Naafs B Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4 Suppl):S21-8. PubMed ID: 9030120 [No Abstract] [Full Text] [Related]
16. The effect of anti-reactional drugs on complement components in the type II, erythema nodosum leprosum, reaction. Sehgal VN; Sharma V; Sharma VK Br J Dermatol; 1988 Aug; 119(2):255-8. PubMed ID: 3166944 [TBL] [Abstract][Full Text] [Related]
17. [Clofazimine. Current status of therapy with clofazimine (Lampren) for leprosy, erythema leprosum , and other dermatoses after donation of the medicine to the WHO by Novartis]. Sunderkötter CH; Lan Ma H Hautarzt; 2005 May; 56(5):478-9. PubMed ID: 15806433 [No Abstract] [Full Text] [Related]
18. Indomethacin in the management of erythema nodosum leprosum--a double-blind controlled trial. Karat AB; Thomas G; Rao PS Lepr Rev; 1969 Jul; 40(3):153-8. PubMed ID: 4900710 [No Abstract] [Full Text] [Related]
19. An internally-controlled double blind trial of thalidomide in severe erythema nodosum leprosum. Waters MF Lepr Rev; 1971 Mar; 42(1):26-42. PubMed ID: 4338720 [No Abstract] [Full Text] [Related]
20. Management of steroid-dependency with clofazimine (Lamprene or B 663 (Geigy)). Morgan J Lepr Rev; 1970 Oct; 41(4):229-32. PubMed ID: 5515679 [No Abstract] [Full Text] [Related] [Next] [New Search]